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PDGF-BB, suggested an increased turnover of caveolin-1 inCaveolae in mesangial cells and caveolin expression in mesan-
mesangial cells stimulated by mitogens.gial proliferative glomerulonephritis.
Conclusion. To our knowledge, this electron microscopicalBackground. Caveolae are plasma membrane invaginations
study is the first to demonstrate the presence of caveolae inthat have a diameter of 40 to 60 nm. Recent evidences have
cultured mesangial cells. Caveolae integrate PDGF receptors,demonstrated that caveolae contain a variety of signal trans-
and caveolin-1 may play a role in the pathogenesis of theduction molecules. Caveolin is a marker protein of caveolae
mesangial proliferative glomerular diseases through PDGF sig-and has been proposed to play a negative regulatory role in
naling.signal transduction. The aim of this study was to investigate
the behavior of caveolae and caveolin in experimental glomeru-
lonephritis, the localization of both platelet-derived growth
factor (PDGF) and transforming growth factor-b (TGF-b) re- Caveolae are non–clathrin-coated membrane invagi-ceptors in the caveolae membrane, and the regulation of caveo-
nations that have a diameter of 40 to 60 nm, enrichedlin expression in cultured mesangial cells.
in free cholesterol and glycolipids. They particularlyMethods. The expression of caveolin-1 was examined by
immunoblotting and immunohistology using anti-caveolin anti- abound in adipocytes, vascular smooth muscle cells, en-
body in anti-Thy-1 nephritis. The caveolae membrane fraction dothelium, and fibroblasts, and they are found in most
of mesangial cells was isolated by sucrose gradient method cells. The functions of caveolae have been reported to
and expression of PDGF receptor and TGF-b receptor were
be transcellular transport of macromolecule, taking updetected by immunoblotting. The effects of mitogens such as
small molecules and delivering them to the cytoplasm,phorbol 12-myristate 13-acetate (PMA) and PDGF on the ex-
regulation of signaling, and definition of cell polarity bypression of caveolin-1 protein and mRNA were also examined
in cultured mesangial cells. sorting glycosylphosphatidylinositol-linked protein [1–3].
Results. Caveolin-1 was mainly expressed in glomeruli and Caveolae have also been thought to be important for
was significantly up-regulated in anti-Thy-1 nephritis rat kid- cell growth, because several hormones, growth factorney. In cultured mesangial cells, the membrane invaginations
receptors {endothelin-1 [4], platelet-derived growth fac-of caveolae were revealed by electron microscopy. PDGF re-
tor (PDGF) [5], and epidermal growth factor (EGF)ceptors abounded in the caveolae membrane and rapidly
changed their subcellular distribution after ligand stimulation. [6]} and signaling molecules (plasma membrane calcium
In contrast, TGF-b receptors abounded in the non-caveolae pump [7], inositol 3,4,5-triphosphate receptor-like pro-
membrane and did not change after ligand stimulation. De- tein [8], src-related kinases [9], Ras and Raf-1 [6]) are
creases in caveolin-1 protein, which were associated with in-
located in them, suggesting that caveolae may functioncreases in mRNA expression after the exposure of PMA or
as unique cell surface signal transduction domains. The
signal transducing proteins are rapidly recruited into ca-
veolae upon PDGF [5] and EGF [6] stimulations. Angio-1 See Editorial by Fine, p. 797.
tensin II (Ang II) stimulates movement of the Ang II
Key words: platelet-derived growth factor, transforming growth
type 1 (AT1) receptors from the general plasma mem-factor-b, signal transduction, growth factor receptors, renal lesion, anti-
Thy-1 nephritis. brane fraction to the caveolae membrane fraction [10].
The movement of the receptors into the caveolae mem-
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as three families (caveolin-1, -2, and -3) [11–13]. Caveolin bedded in TISSUE-TEKt OCT compound (Miles Inc.,
Elkhart, IN, USA) and frozen in liquid nitrogen. Fouris thought to play an important role in the formation of
caveolae membranes [14], acting as scaffolding domains micron cryostat sections were cut onto poly-l-lysine–
coated slides and fixed with acetone. To reveal caveolinto organize and concentrate specific caveolin-interacting
lipids and proteins within the caveolae microdomains. antigenicity, they were pretreated with 1% sodium dodecyl
sulfate (SDS) for five minutes [21]. The labeled streptavi-Caveolin first received attention as a tyrosine phosphory-
lated substrate of the Rous sarcoma viral oncogene upon din-biotin method was used for immunohistochemical
staining (LSAB Kit; Dako, Carpinteria, CA, USA). Briefly,cellular transformation and was subsequently shown to
be associated with caveolae [15]. Caveolin expression the specimens were treated with 0.3% hydrogen perox-
ide for 30 minutes to inhibit endogenous peroxidase. Allcorrelates to some extent with caveolae formation. Thus,
the behavior of caveolae and caveolin may be closely sections were incubated with 1% bovine serum albumin
(BSA) and were then incubated with anti-caveolin-1 anti-related to cell growth induced by growth stimulators.
Caveolin is highly expressed in lung and muscle tissue body (clone; 2297), anti-caveolin-3 antibody (clone; 26)
(Transduction Laboratories, Lexington, KY, USA), orbut is hardly expressed in the kidney, liver, spleen, and
brain tissues [9]. However, in the kidney, the glomeruli anti-OX-7 antibody (Harlan Sera-Lab, Sussex, UK) at
48C overnight. The specificities of both anti-caveolin-1are composed of totally different cells, including mesan-
gial cells from tubular cells. Since mesangial cells have antibody (clone; 2297) and anti-caveolin-3 antibody
(clone; 26) were showed previous reports [22, 23]. Aftersimilar characteristics to vascular smooth muscle cells,
which highly express caveolin, caveolin may also abound washing them in phosphate-buffered saline (PBS; pH
7.4), biotinylated anti-mouse or anti-rabbit IgG second-in the glomeruli.
A variety of cytokines and growth factors has been ary antibody was applied, followed by peroxidase-labeled
streptoavidin. Peroxidase activity was visualized withimplicated in the pathogenesis of renal diseases. Espe-
cially PDGF [16–18] and transforming growth factor-b 3-amino-9-ethylcarbazole, and the sections were faintly
counterstained with Meyer’s hematoxylin. For electron(TGF-b) [19] have been given attention for their role in
pathogenesis of renal lesions. To clarify the participation microscopy, mesangial cells cultured in BIOCOATt cell
culture inserts (Becton Dickinson, Bedford, MA, USA)of caveolae and caveolin-1 in the pathogenesis of prolif-
erative renal lesions, we investigated the distribution and were primarily fixed in 3% glutaraldehyde and then fixed
in 1% osmium tetroxide for one hour at 48C. Then themovement of PDGF receptors or TGF-b receptors in
the caveolae membrane fraction after stimulation of the membrane was transferred into acetone followed by
propylene oxide and embedded in resin. Thin speci-ligands, as well as caveolin-1 expression in response to
mitogens in cultured mesangial cells and in an animal mens, obtained with ultramicrotome, were stained with
1% uranyl acetate and 1% lead citrate in water, usingmodel of kidney disease.
a standard technique and then examined under a JEM-




Glomerular isolationEight male, seven-week-old Wistar rats were housed in
individual cages and were allowed free access to standard Glomeruli were isolated using a graded sieving tech-
nique. A spatula was used to pass minced cortex throughrat chow (Nihon-haigou-shiryou, Aichi, Japan) and tap
water. Four rats were injected intravenously with 0.5 mg a 149 micron nylon screen (Spectrum Medical, Los
Angeles, CA, USA). Tissue that emerged was passedof anti-Thy-1 monoclonal antibody (MoAb 1-22-3) [20],
and four control rats were injected saline. Seven days sequentially through a 105 and 74 micron sieve. Glomer-
uli retained on the 74 micron sieves were removed andafter MoAb 1-22-3 injection, the rats were sacrificed,
and then the kidneys were removed and processed for washed three times in chilled PBS (pH 7.4) and homoge-
nated using a dounce-homogenizer in buffer A [50 mmol/Leither histologic analyses or immunoblot analyses of the
glomeruli. Tris/HCl, pH 8.0, 1 mmol/L ethylenediaminetetraacetic
acid (EDTA), 1 mmol/L dithiothreitol (DTT), 200 mmol/L
Histologic examination sucrose] containing 60 mmol/L n-octylglucoside and pro-
tease inhibitors [1 mmol/L phenylmethylsulfonyl fluorideRenal tissue from each animal was processed and ex-
amined by light and immunohistochemical microscopy. (PMSF), 1 mg/mL leupeptin, and 1 mg/mL aprotinin].
For light microscopy, tissues were fixed in alcoholic Bouin
Mesangial cell culturesolution and neutral-buffered formalin, and were then
embedded in paraffin and cut into 2 micron sections that Glomeruli were aseptically obtained from male
Sprague-Dawley rats by the same method as describedwere stained with periodic acid-Schiff (PAS) stain. For
immunohistochemical analysis, kidney sections were em- previously in this article. Mesangial cells were prepared
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from collagenase-digested glomeruli and maintained in mouse IgG antibody horseradish peroxidase conjugate
RPMI-1640 medium (GIBCO, Grand Island, NY, USA) (Amersham Pharmacia Biotech) for other primary anti-
containing 20% fetal bovine serum (FBS), 100 U/mL bodies. The membranes were washed in PBS-T, and the
penicillin, and 100 mg/mL streptomycin at 378C in a 5% bands were visualized by ECL plus Western blotting
CO2 incubator. Subconfluent monolayers from passages detection system (Amersham Pharmacia Biotech).
between three and seven were used in this study. The
RNA extraction and Northern blottingidentity of mesangial cells was confirmed based on stan-
dard criteria [24, 25]. The mesangial cell monolayers Total cellular RNA was extracted from cultured mes-
were washed twice with serum-free RPMI-1640 medium. angial cells according to the guanidium thiocyanate-phe-
After 24 hours of incubation in serum-free medium, mes- nol-chloroform method [30]. Five micrograms of total
angial cells were exposed to phorbol 12-myristate 13- RNA samples were electrophoresed in a 1% agarose-
acetate (PMA; Sigma, St. Louis, MO, USA), PDGF-BB 0.66 M formaldehyde gels and capillary transferred to
(Becton Dickinson), or TGF-b1 (R&D Systems, Minne- Hybond N1 nylon membranes (Amersham Pharmacia
apolis, MN, USA). After exposure to these substances, Biotech). The membranes were then fixed in 50 mmol/L
the culture medium was removed, and then mesangial NaOH and baked at 1208C for 30 minutes. Rat caveolin-1
cells were homogenated in buffer A or subjected to the c-DNA was obtained from a rat c-DNA library by poly-
following analyses. merase chain reaction (PCR) using the following pri-
mers: upper, 59-ATGTCTGGGGGTAAATACGT-39,Purification of caveolae membrane fractions
and lower, 59-CCTTCTGGTTCCGCAATCAC-39. The
Caveolae membrane domains were purified from cul- fragment was subcloned into pBluescript SK1 phagemid
tured mesangial cells according to a previously described (Invitrogen, Carlsbad, CA, USA) and applied to synthe-
method [26, 27]. Cultured mesangial cells were homoge- size a digoxigenin labeled RNA probe. Briefly, after lin-
nized with 250 mmol/L sodium carbonate (pH 11.0) con- earization with restriction enzymes, labeled RNA was
taining protease inhibitors. The homogenate was ad- synthesized by in vitro transcription from a phage pro-
justed to 45% sucrose by the addition of 90% sucrose moter with dNTP mixture containing digoxigenin labeled
prepared in MES-buffered saline (2-morpholinoethane- UTP (Boehringer Mannheim, Mannheim, Germany).
sulfonic acid monohydrate), pH 6.5. Discontinuous su- Hybridization was performed at 658C for 12 hours. After
crose gradient was formed above the lysate and then blocking, the membranes were incubated with anti-
centrifuged at 39000 r.p.m. for 16 hours. From the top digoxigenin-AP antibody (Boehringer Mannheim) for
of each gradient, 12 fractions were collected. The fifth
one hour, and then mRNA was visualized using CDP-
fraction as the caveolae membrane fraction and a mix-
Start chemiluminescent reagent (Boehringer Mann-ture of the 9th to 12th fractions as the non-caveolae
heim). Ribosomal RNA (18S) stained with ethidium bro-membrane fraction were subjected to SDS-polyacryl-
mide was used as the control for RNA loading.amide gel electrophoresis (SDS-PAGE).
Statistical analysisWestern blot analysis
The blotting bands were digitalized by National Insti-The protein content of the preparation was deter-
tutes of Health image software (Dr. Wayne Rasband,mined by the method of Bradford [28] using BSA as the
National Institutes of Health, Washington, DC, USA).standard. In brief, 5 to 20 mg of protein samples were
To compare data, an unpaired, two-tailed Student t testseparated by SDS-PAGE through 7.5% acrylamide or
was used. Differences were considered statistically sig-12.5% acrylamide gels, using the method of Laemmli [29],
nificant if the P value was less than 0.05.and then electrotransferred to Hybond ECLt nitrocellu-
lose membranes (Amersham Pharmacia Biotech, Buck-
inghamshire, UK). The membranes were blocked for 1.5 RESULTS
hours in buffer containing PBS with 0.1% Tween-20
Presence of caveolae on the plasma membrane of(PBS-T) and 5% dried milk and then incubated for one
mesangial cellshour at 48C with 1:1000 dilution of anti–caveolin-1 anti-
Cultured mesangial cells were analyzed for morphol-body, anti–TGF-b type II receptor antibody (Transduc-
ogy of caveolae by transmission electron microscopy. Ation Laboratories) or anti–PDGF receptor-b antibody
typical thin section electron microscopic view of caveolae(Santa Cruz Biotechnology, Santa Cruz, CA, USA).
is shown in Figure 1. Caveolae of mesangial cells wereAfter incubation with the primary antibody, the mem-
non–clathrin-coated membrane invaginations with a di-branes were washed with PBS-T and incubated for 1.5
ameter of 40 to 60 nm. Caveolae were found on the cellhours with a 1:2000 dilution of an anti-goat IgG antibody
surface and tended to collect near the juxtaposed tohorseradish peroxidase conjugate (Santa Cruz Biotech-
nology) for anti-PDGF receptor-b antibody or anti- stress fibers. They were identified on the basis of their
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protein in glomeruli from anti-Thy-1 nephritis rat com-
pared with control rats (Fig. 4).
Receptor localization of PDGF and TGF-b in the
caveolae membrane
Three isoforms of PDGF (AA, AB, and BB) appear
to act on mesangial cells in autocrine or paracrine fash-
ion, and the cells have the two subunits, a and b, of the
receptors [17, 18, 31]. The majority of mesangial cells
expressed PDGF receptor b subunit [17]. TGF-b recep-
tor consists of two subfamilies, type I and type II recep-
tors. TGF-b1 first binds to the type II receptor. Type I
Fig. 1. Thin-section view of cultured mesangial cellular caveolae. Elec-
receptor can exert TGF-b signals but cannot bind TGF-btron micrograph of a cultured mesangial cell in cross-section showed
caveolae as non–clathrin-coated deep invaginations (arrow heads) in in the absence of the TGF-b type II receptor [32]. Caveo-
the plasma membrane. Bar 100 nm. lae are membrane invaginations that are important for
signal transduction of growth factors. In the present
study, we therefore examined the localization and pro-
tein level of PDGF receptors b and TGF-b type II recep-distinctive, flask-shaped morphology and uniform curva-
tors in the caveolae membrane fraction of cultured mes-ture.
angial cells.
Expression of caveolin-1 in kidney tissue The caveolae membrane and non-caveolae membrane
were fractionated according to a detergent-free sucroseThe kidney sections were immunologically stained
gradient method, and the quantities of PDGF and TGF-bwith anti–caveolin-1 and anti–caveolin-3 antibody and
receptor protein were examined by immunoblotting (Fig.compared between normal rats and anti-Thy-1 nephritis
5). PDGF receptor was strongly detected in the caveolaerats (Fig. 2). In the PAS-stained specimens, mesangial
membrane and to a lesser degree in the non-caveolaecellular proliferation was observed in anti-Thy-1 nephri-
membrane. In contrast, the TGF-b receptor was detectedtis rats (Fig. 2D) but not in control rats (Fig. 2C). Caveo-
mainly in the non-caveolae membrane.lin-1 staining was mainly found in the glomeruli in both
groups and increased glomerular caveolin-1 staining was
Ligand-induced redistribution of growth factorsobserved in anti-Thy-1 nephritis rats compared with con-
receptors in the caveolae membranetrol rats (Fig. 2 A, B). Late distal convoluted tubules,
To investigate ligand-induced redistribution of PDGFconnecting segments in cortex (Fig. 2F) and collecting
receptor or TGF-b receptor, cultured mesangial cellsduct principal cells (Fig. 2E) in medulla, showed basolat-
were briefly incubated with the maximum dose of ligandseral staining of caveolin-1. Parietal epithelium of Bow-
that exerts distinct biological effects. After a 10-minuteman’s capsule (Fig. 2 A, B) and smooth muscle cells of an
incubation, cells were lysated and fractionated to caveo-adjacent arteriole (Fig. 2A) were also positive. Arterial
lae membrane and non-caveolae membrane. The PDGFvascular endothelial cells and smooth muscle cells in
receptor mainly localized in the caveolae membrane bothinterstitium showed intense staining (Fig. 2G). However,
before and after the ligand incubation. However, aneither of the specimens were stained with caveolin-3
marked increase in PDGF receptor protein distribution(data not shown). To identify the main cell source for
was observed in the caveolae membrane after incubationcaveolin-1 production in the glomeruli, renal serial sec-
with the ligand for 10 minutes (Fig. 6). In addition, thetions were stained with anti–caveolin-1 antibody and
PDGF receptor distribution increased in the caveolaeOX-7, a marker of rat mesangial cells. Most of caveolin-
membrane in a dose-dependent manner in the presence1–producing cells were mesangial cells, which were posi-
of PDGF-BB, reaching a peak at 5 ng/mL of PDGF-BBtive for OX-7 (Fig. 3).
(Fig. 7). In contrast, the TGF-b receptor mainly localizedThe tissue homogenates from whole kidney, glomeruli
in the non-caveolae membrane before and after incuba-of rats, and cultured mesangial cells were analyzed by
tion with the ligand for 10 minutes, and its distributionimmunoblotting using anti–caveolin-1 antibody. Caveo-
did not change even in the presence of the maximumlin-1 could not be detected in homogenates from whole
dose of TGF-b1. The increase of PDGF receptor proteinkidneys, but it was detected in homogenates from iso-
in the caveolae membrane was probably caused by li-lated glomeruli. The homogenates from cultured mesan-
gand-induced mobilization of the PDGF receptor in thegial cells contained a large amount of caveolin-1. The
non-caveolae membrane to the caveolae membrane, be-immunoblotting study also demonstrated a 2.0- 6 0.1-
fold (P , 0.001, N 5 4) larger amount of caveolin-1 cause no newly synthesized protein was detected in the
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Fig. 2. Immunohistochemistry for caveolin-1
and periodic acid-Schiff (PAS) staining of kid-
neys from control or anti-Thy-1 nephritis rats.
Renal sections were obtained seven days after
the MoAb 1-22-3 injection. The sections from
control rats (A, C, E, F, and G) or anti-Thy-1
nephritis rats (B and D) were immunohisto-
chemically stained with anti-caveolin-1 anti-
body (A, B, E, F, and G) or stained with PAS
(C and D). In the PAS-stained specimens,
mesangial cellular proliferation was observed
in anti-Thy-1 nephritis rats (D) but not in con-
trol rats (C). Caveolin-1 staining was mainly
found in the glomeruli in both groups, and
increased glomerular caveolin-1 staining was
observed in anti-Thy-1 nephritis rats (B) com-
pared with control rats (A). Late distal convo-
luted tubules, connecting segments in cortex
(F), and collecting duct principal cells (E) in
medulla showed basolateral staining of caveo-
lin-1. Parietal epithelium of Bowman’s capsule
(A and B) and smooth muscle cells of an adja-
cent arteriole (A) were also positive. Arterial
vascular endothelial cells and smooth muscle
cells in interstitium showed intense staining
(G). Magnifications are 3400 (G), 3200 (A,
B, E, and F), 3100 (C and D).
Fig. 3. Immunohistochemistry for OX-7 and
caveolin-1 in serial renal sections from control
rats. Serial renal sections from control rats
were immunohistochemically stained with anti-
caveolin-1 antibody (A) or anti-OX-7 antibody
(B). Magnification 3200.
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Fig. 4. Immunoblot analyses of caveolin-1 in
cultured mesangial cells, isolated glomeruli,
whole kidney tissue homogenates from control
rats, and isolated glomeruli homogenates from
control or anti-Thy-1 nephritis rats. Twenty-
microgram protein samples were subjected to
12.5% SDS-PAGE, electrophoretically trans-
ferred to a membrane, and immunoblotted
using anti-caveolin-1 antibody. The bar graph
shows the relative ratio in densitometric anal-
ysis of caveolin-1 protein of glomeruli from
anti-Thy-1 nephritis rats versus control rats.
The results are the mean 6 SEM of four ex-
periments.
Fig. 6. Ligand-induced redistribution of PDGF receptor b (PDGFR-b)
and TGF-b type II receptor (TGF-b type II R). Cultured mesangial
cells were incubated with serum-free medium or serum-free medium
containing a maximum dose of PDGF-BB (10 ng/mL) or TGF-b1 (10
ng/mL) for 10 minutes. Then the cells were homogenated and fraction-
ated into the caveolae membrane (CM) and non-caveolae membraneFig. 5. Localization of platelet-derived growth factor receptor b
(NCM) fractions by ultracentrifugation through a sucrose gradient.(PDGFR-b) and transforming growth factor-b type II receptor (TGF-b
Five micrograms of protein samples were subjected to SDS-PAGE andtype II R) in the caveolae membrane (CM) and non-caveolae membrane
immunoblotted using anti-PDGFR antibody or anti-TGF-b type-II R(NCM) of mesangial cells. The cells were homogenated and fractionated
antibody. A marked increase in PDGF receptor protein distributioninto CM and NCM. Five micrograms of protein samples were subjected
was observed in the CM fraction after incubation with PDGF-BB forto SDS-PAGE and immunoblotted using anti-PDGFR antibody, anti-
10 minutes. In contrast the TGF-b receptor, distribution did not changeTGF-b type II R antibody and anti-caveolin-1 antibody. The mesangial
after incubation with TGF-b. Results are representative of three sepa-cell homogenate was completely fractionated into CM and NCM as
rate experiments.indicated (caveolin-1 protein). PDGFR protein was strongly detected
in the CM fraction and to a lesser degree in the NCM fraction. In
contrast, TGF-b type II R protein was detected mainly in the NCM
fraction. Results are representative of three separate experiments.
then were gradually increased up to 24 hours during
PMA incubation. Meanwhile, caveolin-1 mRNA levels
were gradually increased up to 2 hours and then gradu-cell homogenate after incubation with the ligand for only
ally decreased up to 24 hours in contrast to its effect on10 minutes.
protein levels (Fig. 8A). Similarly, caveolin-1 protein
Effect of PMA and PDGF on caveolin-1 expression in levels were gradually decreased up to 4 hours and then
cultured mesangial cell gradually increased up to 24 hours, and caveolin-1
mRNA levels were gradually increased up to 8 hoursProtein kinase C (PKC) is one of the typical intracellu-
and then gradually decreased up to 24 hours duringlar signal transducers and is colocalized with caveolin-1
PDGF-BB incubation (Fig. 8B).[33]. PKC is activated in glomerular diseases in mesangial
Increasing doses of PMA and PDGF-BB were addedcells and has pivotal role in diabetic glomerulosclerosis
to the culture medium. Immunoblot study of caveolin-1[34, 35]. To examine the regulatory mechanism caveolin-1,
revealed that both PMA and PDGF-BB reduced caveo-we evaluated caveolin-1 expression during activation of
lin-1 protein levels in a dose-dependent manner (Fig. 9).PKC by PMA, a potent general PKC activator, and dur-
Conversely, Northern blot study revealed that both PMAing activation of the PDGF receptor by PDGF-BB.
and PDGF-BB increased caveolin-1 mRNA expressionTime-dependent studies showed that caveolin-1 protein
levels were gradually decreased up to two hours and in a dose-dependent manner (Fig. 10). Reciprocal changes
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meric complex in many cell types [38, 39], whereas caveo-
lin-3 is muscle specific [27]. Caveolin-1 and -3 generally
have higher regulatory activity than caveolin-2. We
therefore examined the expression of caveolin-1 and -3.
The present study showed that glomeruli were stained
with caveolin-1, but not with caveolin-3, and caveolin-1
was present mainly in mesangial cells. As previously
reported, caveolin-1 was also present in the parietal cells
of Bowman’s capsule, distal tubules, connecting tubule
cells, and collecting duct cells [22]. In the anti-Thy-1
nephritis rats, increased glomerular caveolin-1 protein
level was accompanied by mesangial cellular prolifera-
Fig. 7. Dose-dependent effect of PDGF-BB on PDGF receptor b tion, suggesting that caveolin-1 plays some roles in prolif-
(PDGFR-b) protein in the caveolae membrane. Cultured mesangial erative glomerular diseases. Thus, in this study, we have
cells were incubated with serum-free medium containing increasing
demonstrated higher glomerular caveolin-1 expressiondoses of PDGF-BB for 10 minutes. Then the cells were homogenated
and fractionated into the caveolae membrane and non-caveolae mem- in renal tissue and altered caveolin-1 expression in a
brane fractions through an ultracentrifugation using sucrose gradient. pathological condition.
Five micrograms of caveolae membrane protein samples were subjected
Mesangial cells have a potent ability to proliferate,to 7.5% SDS-PAGE, for immunoblotting of PDGFR, electrophoreti-
cally transferred to a membrane, and immunoblotted using anti-PDGFR causing many lesions in a variety of glomerular diseases.
antibody. The line graph shows the relative ratio in densitometric analy- Caveolae have been thought to be important for cell
sis of PDGFR protein versus control. The distribution of the PDGF
growth, because several hormones, growth factor recep-receptor increased in a dose-dependent manner in the caveolae mem-
brane. Results are representative of three separate experiments. tors, and signaling molecules are located in these regions,
suggesting that caveolae may function as unique cell
surface signal transduction domains. The signal-trans-
ducing proteins are rapidly recruited into caveolae upon
between protein expression and mRNA expression in PDGF [40] and EGF [6] stimulation. PDGF is a potent
a time-dependent study and the decrease in caveolin-1 mitogen for mesangial cells [16]. Increased expression of
protein level with an increase in caveolin-1 mRNA ex- PDGF is a common finding in human and experimental
pression in a dose-dependent study suggest that PMA glomerular lesions [17, 18, 41]. The effect of PDGF on
and PDGF increased the turnover or degradation of mesangial cell proliferation may be influenced by caveolin
caveolin-1. expression. Caveolin directly regulates more than 50 mole-
cules, which colocalize with caveolin in the caveolae mem-
brane. Caveolin suppresses numerous cellular signalings,DISCUSSION
while it stimulates only the insulin receptor signaling [42].
Caveolae were first identified as distinctive membrane In the course of cellular differentiation, up-regulation of
invaginations on the cell surface. The shape of the mem- caveolin is accompanied by either a decrease in growth
brane suggested that they were involved in endocytosis. factor signaling or an increase in insulin receptor signal-
Indeed, caveolae have been reported to play a role in the ing [43, 44]. In the present study, PDGF receptor abounded
uptake of bulk proteins from blood, the internalization of in the caveolae membrane of mesangial cells. The PDGF
small molecules such as folate by potocytosis [36], and receptor belongs to a family of growth factor receptors
the internalization of glycolipid binding toxins [37]. Dur- that transmit information across the membrane by stimu-
ing potocytosis, caveolae internalize molecules in a cyclic lating the phosphorylation of specific effectors such as
process involving a progressive invagination of the plasma PI3-kinase, non-receptor tyrosine kinase, protein-tyro-
membrane, formation of a closed, vesicle-like compart- sine phosphatases, and various adaptor molecules. Re-
ment, and the return of the vesicle to the plasma mem- cently, caveolae have been identified as a site in which
brane. Mesangial cells are expected to have many caveo- several PDGF receptor effector molecules are concen-
lae because mesangial cells have similar characteristics trated [5].
to vascular smooth muscle cells, which have abundant Previous reports have indicated ligand-induced mobi-
caveolae. Our present electron microscopic study is the lization of the M2 muscarinic receptor [45], bradykinin
first to reveal the presence of caveolae in cultured mesan- receptor [46], and b-adrenergic receptor [1] into the ca-
gial cells. veolae fractions. Angiotensin II also stimulates mobiliza-
Caveolin is important for the formation of caveolae tion of the AT1 receptors from the non-caveolae fraction
membranes, which act as scaffolding domains. The ca- to the caveolae fraction [10]. In the present study, PDGF
veolin family consists of caveolin-1, -2, and -3 [11, 13]. stimulation augmented the mobilization of PDGF recep-
tor into the caveolae membrane in mesangial cells. TheCaveolin-1 and -2 coexpress and form a hetero-oligo-
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Fig. 8. Time-dependent effects of phorbol
12-myristate 13-acetate (PMA) and PDGF-
BB on caveolin-1 protein and mRNA in cul-
tured mesangial cells. Cultured mesangial cells
were incubated with serum-free medium con-
taining PMA (1028 mol/L; A) or PDGF-BB
(10 ng/mL; B) for the consecutive times.
Twenty microgram protein samples of total
homogenates were subjected to 12.5% SDS-
PAGE and electrophoretically transferred to
a membrane and immunoblotted using anti-
caveolin-1 antibody [immunoblot (IB)]. The
upper line graphs show the relative ratios in
densitometric analyses of caveolin-1 protein
versus control. Five-microgram total RNA
samples were subjected to 1% agarose electro-
phoresis, blotted onto a nylon membrane, and
hybridized with a digoxigenin-labeled RNA
probe for caveolin-1. Ribosomal RNAs (18S)
stained with ethidium bromide are shown as
the control [Northern blot (NB)]. The lower
line graphs show the relative ratios in densi-
tometric analyses of caveolin-1 mRNA/18S
rRNA versus control. Protein expression and
mRNA expression inversely changed each
other in both PMA and PDGF-BB incubation.
Results are representative of three separate
experiments.
Fig. 9. Dose-dependent effects of PMA and
PDGF-BB on caveolin-1 protein in cultured
mesangial cells. Cultured mesangial cells were
incubated with serum-free medium containing
increasing doses of PMA (A) for two hours or
PDGF-BB (B) for four hours and then homog-
enated. Twenty-microgram protein samples of
total homogenates were subjected to 12.5%
SDS-PAGE, electrophoretically transferred to
a membrane, and immunoblotted using anti-
caveolin-1 antibody. The line graph shows the
relative ratio in densitometric analysis of ca-
veolin-1 protein versus control. Both PMA
and PDGF-BB reduced caveolin-1 protein in
mesangial cells dose dependently. Results are
representative of three separate experiments.
Fig. 10. Effects of PMA and PDGF on caveo-
lin-1 mRNA expression in cultured mesangial
cells. Cultured mesangial cells were incubated
with serum-free medium containing increas-
ing doses of PMA (A) for two hours or PDGF-
BB (B) for eight hours. At the end of the
incubation period, total RNA was extracted,
subjected to 1% agarose electrophoresis, blot-
ted onto a nylon membrane, and hybridized
with a digoxigenin-labeled RNA probe for ca-
veolin-1. Ribosomal RNAs (18S) stained with
ethidium bromide are shown as the control.
The line graph shows the relative ratio in den-
sitometric analysis of caveolin-1 mRNA/18S
rRNA versus control. Both PMA and PDGF-
BB increased caveolin mRNA in mesangial
cells dose dependently. Results are represen-
tative of three separate experiments.
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finding that PDGF receptors colocalized with caveolin-1 cytokines are involved in proliferative glomerular le-
supports the notion that caveolin may act as an organiz- sions. Some of them may down-regulate caveolin expres-
ing molecule for signal transduction of the PDGF recep- sion like PDGF, while others may up-regulate it. Fur-
tor. PDGF receptor integration by caveolin in cultured thermore, the turnover of caveolin-1 protein may differ
mesangial cell suggests that caveolae and caveolin are at each stage of cell proliferation. Proliferative stimula-
involved in the progression of mesangial cell prolifera- tion and inhibition are well balanced in cellular prolifera-
tive glomerular diseases through PDGF signaling. tion of normal tissues. Since caveolin-1 exerts suppressor
In contrast, TGF-b receptors belong to a TGF-b family effects on cell proliferation, overexpression of caveolin-1
receptor that has the intracellular domain of serin-threo- may be reasonably assumed to regulate cellular prolifer-
nin kinase. TGF-b type II receptor was mostly localized ation in inflammatory tissues. Further investigations to
in the non-caveolae membrane, and the receptor move- clarify the role of caveolin-1 in proliferative glomerular
ment to the caveolae membrane from the non-caveolae diseases are needed.
membrane was not observed after ligand mediated in- In summary, the present study demonstrated the in-
duction, indicating that caveolae are not involved in sig- creased glomerular caveolin-1 expression in diseased
nal transduction of the TGF-b receptor. TGF-b signaling kidney and the presence of caveolae in cultured mesan-
in cell membrane is complicated. TGF-b first binds to gial cell for the first time. PDGF receptor abounded in
the type II receptor, which exists in an oligomeric form caveolae and rapidly changed their subcellular distribu-
with activated kinase, and finally, type I receptor is re- tions after ligand-mediated stimulation. Although the
cruited into the complex [32, 47]. All TGF-b receptors regulatory mechanisms of caveolin-1 are still unclear,
lack a common amino acid sequence motifs of caveolin activation of the caveolin-related signaling pathway may
binding molecules (CXCXXXXC or CXXXXCXXC, increase turnover or degradation of caveolin-1 protein.
where C is an aromatic residue), which is specific for
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